Epidemiology and pathogenesis research progress of cancer-related fatigue

Abstract

CHEN Hong-Shan, WANG Yu-Dong, LIU Wei. Epidemiology and pathogenesis research progress of cancer-related fatigue[J]. Journal of International Oncology, 2014, 41(3): 187-190.

［1］ Minton O, Berger A, Barsevick A, et al. Cancerrelated fatigue and its impact on functioning［J］. Cancer, 2013, 119Suppl11:21242130. ［2］ Bower JE, Lamkin DM. Inflammation and cancerrelated fatigue:Mechanisms,coutributing factors,and treatment implications［J］. Brain Behav Immun, 2013Suppl:S4857. ［3］ Tazi el M, Errihani H. Evaluation and management of fatigue in oncology:a multidimensional approach［J］.Indian J Palliat Care， 2011, 17(2):9297. ［4］ Berger AM, Gerber LH, Mayer DK. Cancerrelated fatigue:implications for breast cancer survivors［J］. Cancer, 2012,118(8Suppl):22612269. ［5］ Yun YH, Lee KS, Kim YW, et al. Webbased tailored deucation program for diseasefree cancer survivors with cancerrelated fatigue:a randomized controlled trial［J］. J Clin Oncol, 2012, 30(12):12961303. ［6］ Minton O, Stone P. A systematic review of the scales used for the measurement of cancerrelated fatigue (CRF)［J］. Ann Oncol, 2009, 20(1):1725. ［7］ Homeber M, Flscher I, Dlmeo F, et al. Cancerrelated fatigue:epidemiology,pathogenesis,diagnosis,and treatment［J］. Dtsch Arztebl Int, 2012, 109(9):161172. ［8］ Alfano CM, Imayama I, Neuhouser ML, et al. Fatigue,inflammation,and ω3 and ω6 fatty acid intake among breast cancer survivors［J］. J Clin Oncol, 2012, 30(20):12801287. ［9］ Moraska AR, Sood A, Dakhil SR, et al. Phase Ⅲ,randomized,doubleblind,placebocontrolled study of longacting methylphenidate for cancerrelated fatigue:North Central Cancer Treatment Group NCCTGN05C7 trial［J］. J Clin Oncol, 2010, 28(23):36733679. ［10］ Bower JE, Ganz PA, Irwin MR, et al. Inflammation and behavioral symptoms after breast cancer treatment:do fatigue,depression,and sleep disturbance share a common underlying mechanism?［J］. J Clin Oncol, 2011, 29(26):35173522. ［11］ Inagaki M, Isono M, Okuyama T, et al. Plasma interleukin6 and fatigue in terminally ill cancer patients［J］. J Pain Symptom Manage, 2008, 35(2):153161. ［12］ Berger AM. Update on the state of the science:sleepwake disturbances in adult patients with cancer［J］. Oncol Nurs Forum, 2009, 36(4):E165177. ［13］ Wang XS, Shi Q, Williams LA, et al. Inflammatory Cytokines are associated with the development of symptom burden in patients with nsclc undergoing concurrent chemoradiation therapy［J］. Brain Behav Immun, 2010, 24(6):968974. ［14］ Wang XS, Williams LA, Krishnan S, et al. Serum sTNFR1,IL6,and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy［J］. Brain Behav Immun, 2012, 26(5):699705. ［15］ Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer［J］. Clin Cancer Res, 2009, 15(1):55345540. ［16］ Barsevick A, Frost M, Zwinderman A, et al. I′m so Tired:Biological and Genetic Mechanisms of Cancerrelated Fatigue［J］. Qual Life Res, 2010, 19(10):14191427. ［17］ Bower JE, Ganz PA, Irwin MR, et al. Fatigue and gene expression in human leukocytes:Increased NFκB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue［J］. Brain Behav Immun, 2011, 25(1):147150. ［18］ ColladoHidalgo A, Bower JE, Ganz PA, et al. Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings［J］. Brain Behav Immun, 2008, 22(8):11971200. ［19］ Miaskowski C, Dodd M, Lee K, et al. Preliminary evidence of an association between a functional interleukin6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers［J］. J Pain Symp Manage, 2010, 40 (4): 531544. ［20］ Jim HS, Park JY, PermuthWey J, et al. Genetic Predictors of Fatigue in Prostate Cancer Patients Treated with Androgen Deprivation Therapy: Preliminary Findings［J］. Brain Behav Immun, 2012, 26(7):10301036.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Epidemiology and pathogenesis research progress of cancer-related fatigue

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments